Scagnelli Robert J, Patel Varun, Peris-Celda Maria, Kenning Tyler J, Pinheiro-Neto Carlos D
Albany Medical College, Albany, New York, USA.
Division of Otolaryngology/Head and Neck Surgery, Department of Surgery, Albany Medical Center, Albany, New York, USA.
World Neurosurg. 2019 Feb;122:e506-e511. doi: 10.1016/j.wneu.2018.10.090. Epub 2018 Oct 25.
Cerebrospinal fluid (CSF) leak is a common complication after surgeries involving sellar reconstruction. Various techniques, including the nasoseptal flap, have been developed to limit postoperative CSF leak. However, the nasoseptal flap causes complications owing to donor site morbidity. A free mucosal graft may be just as effective in reducing CSF leaks as well as reducing postoperative nasal discomfort. This study aimed to assess operative outcomes of free mucosal graft after pituitary resection.
A retrospective chart review was performed for patients who underwent endoscopic endonasal resection of pituitary adenomas. The following data were collected: demographic data, intraoperative CSF leak, postoperative CSF leak, other complications, and mucosal graft healing at 1 month. Also, the Sinonasal Outcome Test-22 was administered preoperatively and 1 month and 3 months postoperatively.
Charts of 158 patients were reviewed, including patients who underwent no mucosal reconstruction, free mucosal graft reconstruction, and nasoseptal flap reconstruction. There was a 7.4% postoperative CSF leak rate in patients who underwent no reconstruction (n = 27), whereas postoperative CSF leak rate was 0.82% in patients undergoing free mucosal graft reconstruction (n = 122) (P < 0.05). Sinonasal Outcome Test-22 scores for patients with free mucosal graft reconstruction showed no significant worsening postoperatively.
The free mucosal graft is a simple and effective means of sellar reconstruction in patients undergoing endonasal endoscopic pituitary resection, and its efficacy is similar to nasoseptal flaps. The free mucosal graft technique does not worsen sinonasal morbidity postoperatively.
脑脊液漏是鞍区重建手术后的常见并发症。已开发出多种技术,包括鼻中隔瓣,以限制术后脑脊液漏。然而,鼻中隔瓣因供区并发症而导致问题。游离黏膜移植在减少脑脊液漏以及减轻术后鼻腔不适方面可能同样有效。本研究旨在评估垂体切除术后游离黏膜移植的手术效果。
对接受内镜下经鼻垂体腺瘤切除术的患者进行回顾性病历审查。收集以下数据:人口统计学数据、术中脑脊液漏、术后脑脊液漏、其他并发症以及1个月时的黏膜移植愈合情况。此外,在术前、术后1个月和3个月进行鼻鼻窦结局测试-22。
回顾了158例患者的病历,包括未进行黏膜重建、游离黏膜移植重建和鼻中隔瓣重建的患者。未进行重建的患者(n = 27)术后脑脊液漏发生率为7.4%,而接受游离黏膜移植重建的患者(n = 122)术后脑脊液漏发生率为0.82%(P < 0.05)。接受游离黏膜移植重建的患者鼻鼻窦结局测试-22评分术后无明显恶化。
游离黏膜移植是经鼻内镜垂体切除术患者鞍区重建的一种简单有效的方法,其效果与鼻中隔瓣相似。游离黏膜移植技术不会使术后鼻鼻窦发病率恶化。